CVET

Covetrus, Inc. [CVET] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CVET Stock Summary

In the News

09:51 04 Dec 2022 CVET

CD&R, TPG Take Covetrus Private In $4B Deal

Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ: CVET) for $21.00 per share, representing an enterprise value of approximately $4 billion. CD&R and its affiliates.

08:49 04 Dec 2022 CVET

Covetrus going private in $4 billion deal

Animal health company Covetrus Inc. CVET, -0.20% said Wednesday it agreed to be taken private by Clayton, Dubilier & Rice (CD&R) and TPG Capital TPG, -0.90% in a deal valued at $4 billion. The two private equity firms agreed to pay $21 a share, which is $1.34 or 6.8% over its closing price of $19.66 a share on Tuesday and a 39% premium over its 30-day volume weighted average price per share as of the unaffected stock price as of May 13.

08:44 04 Dec 2022 CVET

Covetrus to Be Taken Private for $4 Billion

Private-equity firms CD&R and TPG Capital will pay $21 a share to acquire the veterinary services company.

08:29 04 Dec 2022 CVET

Covetrus Gets Private-Equity Buyout Offer at $21 a Share

CD&R and TPG offer to pay $21 a share in cash for Covetrus, which develops technologies and services for the animal health industry.

08:19 04 Dec 2022 CVET

Covetrus (CVET) Q1 Earnings Surpass Estimates

Covetrus (CVET) delivered earnings and revenue surprises of 8.70% and 0.32%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

11:22 04 Dec 2022 CVET

Covetrus, Inc. (CVET) CEO Ben Wolin on Q4 2021 Results - Earnings Call Transcript

Covetrus, Inc. (CVET) CEO Ben Wolin on Q4 2021 Results - Earnings Call Transcript

08:00 04 Dec 2022 CVET

Covetrus (CVET) Q4 Earnings Surpass Estimates

Covetrus (CVET) delivered earnings and revenue surprises of 4% and 1.40%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

07:04 04 Dec 2022 CVET

Covetrus (CVET) Matches Q3 Earnings Estimates

Covetrus (CVET) delivered earnings and revenue surprises of 0.00% and -0.21%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

04:31 04 Dec 2022 CVET

Covetrus: Q3 Earnings Insights

Covetrus (NASDAQ:CVET) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

08:30 04 Dec 2022 CVET

Covetrus Announces Third Quarter 2021 Earnings Release Date and Conference Call Information

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus will release Q3 2021 results after the market close on Thursday, November 4, 2021 and the company will hold a conference call at 4:30 PM ET.

CVET Financial details

Company Rating
Buy
Market Cap
2.94B
Income
-13M
Revenue
4.65B
Book val./share
10.75
Cash/share
0.62
Dividend
-
Dividend %
-
Employees
4.04K
Optionable
No
Shortable
Yes
Earnings
02 Nov 2022
P/E
-226.05
Forward P/E
21.86
PEG
59.65
P/S
0.63
P/B
1.95
P/C
33.85
P/FCF
1469.3
Quick Ratio
1.01
Current Ratio
1.88
Debt / Equity
0.65
LT Debt / Equity
0.64
-
-
EPS (TTM)
-0.1
EPS next Y
0.96
EPS next Q
0.26
EPS this Y
142.21%
EPS next Y
-1055%
EPS next 5Y
-1055%
EPS last 5Y
NAN%
Revenue last 5Y
5.03%
Revenue Q/Q
6.01%
EPS Q/Q
50%
-
-
-
-
SMA20
-42.86%
SMA50
-42.86%
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
-1%
ROC
-
Gross Margin
19%
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
140.12M
Shs Float
105.28M
-
-
-
-
Target Price
-
52W Range
13.39-21.2
52W High
-0.05%
52W Low
+61.46%
RSI
1
Rel Volume
4.36
Avg Volume
1.22M
Volume
5.3M
Perf Week
0%
Perf Month
0.43%
Perf Quarter
-
Perf Half Y
0.82%
-
-
-
-
Beta
1.50574
-
-
Volatility
10.39%, 7.11%
Prev Close
-
Price
20.99
Change
-

CVET Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2019-12-312020-12-31 2021-12-31
Revenue per share
37.1636.7733.39
Net income per share
-9.52-0.16-0.39
Operating cash flow per share
0.960.450.74
Free cash flow per share
0.6-0.040.31
Cash per share
1.212.461.34
Book value per share
11.7413.0311.03
Tangible book value per share
-5.06-1.74-1.28
Share holders equity per share
11.7413.0311.03
Interest debt per share
11.629.467.87
Market cap
1.4B4.02B2.41B
Enterprise value
2.46B4.8B3.27B
P/E ratio
-1.37-211.59-44.6
Price to sales ratio
0.350.930.53
POCF ratio
13.5975.8523.61
PFCF ratio
21.87-804.0557.34
P/B Ratio
1.112.621.59
PTB ratio
1.112.621.59
EV to sales
0.621.110.72
Enterprise value over EBITDA
-3.0922.7518.38
EV to operating cash flow
23.8590.5532.07
EV to free cash flow
38.38-959.8577.89
Earnings yield
-0.730-0.02
Free cash flow yield
0.0500.02
Debt to equity
0.90.690.67
Debt to assets
0.630.560.56
Net debt to EBITDA
-1.333.694.85
Current ratio
1.622.071.94
Interest coverage
-17.8-1.47-0.72
Income quality
-0.1-2.79-1.89
Dividend Yield
0.8400
Payout ratio
-1.15-0.320
Sales general and administrative to revenue
0.20.20
Research and developement to revenue
000
Intangibles to total assets
0.530.50.49
Capex to operating cash flow
-0.38-1.09-0.59
Capex to revenue
-0.01-0.01-0.01
Capex to depreciation
-0.22-0.31-0.3
Stock based compensation to revenue
0.010.010.01
Graham number
50.156.879.89
ROIC
-0.39-0.02-0.01
Return on tangible assets
-0.65-0.01-0.03
Graham Net
-12.03-8.25-7.36
Working capital
511M740M653M
Tangible asset value
-541M-205M-175M
Net current asset value
-765M-528M-548M
Invested capital
0.950.70.69
Average receivables
533.5M574M564.5M
Average payables
462.5M405M423.5M
Average inventory
583M530M556.5M
Days sales outstanding
45.2648.2944.28
Days payables outstanding
58.8241.7543.4
Days of inventory on hand
71.9454.6357.25
Receivables turnover
8.067.568.24
Payables turnover
6.218.748.41
Inventory turnover
5.076.686.38
ROE
-0.81-0.01-0.04
Capex per share
-0.36-0.49-0.44

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
8.688.488.138.328.69
Net income per share
-0.23-0.03-0.02-0.01-0.03
Operating cash flow per share
0.420.430.32-0.24-0.04
Free cash flow per share
0.340.330.16-0.32-0.15
Cash per share
1.681.361.330.850.62
Book value per share
10.9610.9610.9511.0710.75
Tangible book value per share
-1.23-1.64-1.27-0.95-0.86
Share holders equity per share
10.9610.9610.9511.0710.75
Interest debt per share
7.887.897.627.647.54
Market cap
3.7B2.49B2.76B2.32B2.91B
Enterprise value
4.54B3.37B3.62B3.25B3.87B
P/E ratio
-29.83-155.32-229.65-289.63-181.56
Price to sales ratio
3.112.142.462.022.39
POCF ratio
63.7842.1262.63-70.21-484.17
PFCF ratio
78.755.23125.27-52.66-138.33
P/B Ratio
2.461.651.821.521.93
PTB ratio
2.461.651.821.521.93
EV to sales
3.822.93.232.833.18
Enterprise value over EBITDA
100.8978.47757.9874.37
EV to operating cash flow
78.2857.1482.25-98.39-644.5
EV to free cash flow
96.674.92164.49-73.8-184.14
Earnings yield
-0.010000
Free cash flow yield
0.010.020.01-0.02-0.01
Debt to equity
0.690.680.670.650.65
Debt to assets
0.560.560.560.550.55
Net debt to EBITDA
18.6920.618.3616.6118.5
Current ratio
21.891.941.861.88
Interest coverage
-1-0.5-1.170.860.57
Income quality
-1.87-14.75-14.6716.51.5
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.490.50.490.480.48
Capex to operating cash flow
-0.19-0.24-0.50.332.5
Capex to revenue
-0.01-0.01-0.02-0.01-0.01
Capex to depreciation
-0.2-0.29-0.43-0.23-0.31
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
7.472.682.311.92.63
ROIC
00000
Return on tangible assets
-0.020000
Graham Net
-6.98-7.51-7.31-7.38-7.13
Working capital
710M637M653M655M645M
Tangible asset value
-169M-224M-175M-131M-121M
Net current asset value
-493M-567M-548M-503M-493M
Invested capital
0.710.710.690.690.7
Average receivables
611.5M597.5M591M627M641.5M
Average payables
467M467.5M474.5M507M476.5M
Average inventory
593.5M591M606.5M630M608.5M
Days sales outstanding
45.1143.9944.5249.1648.51
Days payables outstanding
39.6640.7243.7149.4440.63
Days of inventory on hand
51.7352.5257.6661.4353.47
Receivables turnover
1.992.052.021.831.86
Payables turnover
2.272.212.061.822.22
Inventory turnover
1.741.711.561.471.68
ROE
-0.020000
Capex per share
-0.08-0.1-0.16-0.08-0.11

CVET Frequently Asked Questions

What is Covetrus, Inc. stock symbol ?

Covetrus, Inc. is a US stock , located in Portland of Maine and trading under the symbol CVET

What is Covetrus, Inc. stock quote today ?

Covetrus, Inc. stock price is $20.99 today.

Is Covetrus, Inc. stock public?

Yes, Covetrus, Inc. is a publicly traded company.

Something similar